Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

La Jolla Pharma focuses on regenerative medicine following acquisition of GliaMed's RILs

April 11, 2011

Zacharon and Pfizer join to develop drugs for orphan diseases

April 8, 2011

Medicago enters research collaboration for noninfluenza vaccine candidate

April 8, 2011

Bradmer Pharma ends Neuradiab license agreement for glioblastoma multiforme

April 8, 2011

DSP and BBI sign option license agreement for anticancer drug

April 8, 2011

OBT to use BioWa's Potelligent technology for cancer programs

April 8, 2011

Novartis to sell global rights for Elidel to Meda

April 8, 2011

Optimer and Cubist Pharma to copromote Dificid for Clostridium difficile infection

April 8, 2011

PRISM and Eisai collaborate on PRI-724

April 8, 2011

Millenium Pharma and Sunesis Pharma enter agreement for kinase inhibitors in oncology

April 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.